We are live on ! Find out more
XAGEW

Longevity Health Holdings, Inc. Warrant

Delisted

XAGEW was delisted on the 11th of September, 2025.

15 hedge funds and large institutions have $789K invested in Longevity Health Holdings, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

7% more funds holding

Funds holding: 1415 (+1)

54% less capital invested

Capital invested by funds: $1.73M → $789K (-$941K)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
Closed
4
Calls
$122K
Puts
Net Calls
+$122K
Net Calls Change
-$236K

XAGEW Hedge Fund Activity: Q2 2022 in Review

15 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Warrant (XAGEW) for Q2 2022, worth a combined $789K — down 54% from $1.73M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new XAGEW positions and 4 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Antara Capital, opening a new position worth an estimated $115K. The largest seller was Exos Asset Management, exiting entirely with an estimated $40K sold.

  • 15 institutional investors held Longevity Health Holdings, Inc. Warrant (XAGEW) as of Q2 2022, up from 14 in Q1 2022.
  • Funds reported $789K of Longevity Health Holdings, Inc. Warrant stock for Q2 2022, down 54% quarter-over-quarter.
  • 5 funds opened new Longevity Health Holdings, Inc. Warrant positions in Q2 2022 and 4 closed out, a net change of +1 holder.
  • The largest Longevity Health Holdings, Inc. Warrant buyer in Q2 2022 was Antara Capital, an estimated $115K added.
  • The largest Longevity Health Holdings, Inc. Warrant seller in Q2 2022 was Exos Asset Management, an estimated $40K sold.

Based on aggregated 13F filings for Q2 2022.